AIP
IPSC icon

Ameritas Investment Partners’s Century Therapeutics IPSC Stock Holding History

Ameritas Investment Partners’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-905
Closed -$431 – 3267
2025
Q1 		$431 Hold
905
– – ﹤0.01% 3122
2024
Q4 		$914 Hold
905
– – ﹤0.01% 3122
2024
Q3 		$1.55K Hold
905
– – ﹤0.01% 3105
2024
Q2 		$2.31K Hold
905
– – ﹤0.01% 3091
2024
Q1 		$3.78K Hold
905
– – ﹤0.01% 2983
2023
Q4 		$3K Hold
905
– – ﹤0.01% 3032
2023
Q3 		$1.81K Hold
905
– – ﹤0.01% 3078
2023
Q2 		$2.86K Hold
905
– – ﹤0.01% 3071
2023
Q1 		$3.14K Hold
905
– – ﹤0.01% 2929
2022
Q4 		$4.1K Hold
905
– – ﹤0.01% 2947
2022
Q3 		$8K Hold
905
– – ﹤0.01% 2852
2022
Q2 		$7K Hold
905
– – ﹤0.01% 2912
2022
Q1 		$11K Hold
905
– – ﹤0.01% 2761
2021
Q4 		$14K Hold
905
– – ﹤0.01% 2786
2021
Q3 		$23K Buy
+905
New +$24.5K ﹤0.01% 2622

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameritas Investment Partners's IPSC Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Century Therapeutics (IPSC) in Q2 2025, closing a stake of 905 shares — an estimated $431 sold.

Ameritas Investment Partners first reported a position in IPSC in Q3 2021 and held it in 15 quarters. The position peaked at $23K in Q3 2021. 65 funds tracked by Wall St. Rank hold IPSC as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Century Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 905 Century Therapeutics shares in Q2 2025, an estimated $431.
  • Ameritas Investment Partners first reported a position in Century Therapeutics in Q3 2021 and held it in 15 quarters.
  • Ameritas Investment Partners's Century Therapeutics position peaked at $23K in Q3 2021.
  • 65 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.